Literature DB >> 3082409

Amodiaquine induced agranulocytosis: inhibition of colony growth in bone marrow by antimalarial agents.

E G Rhodes, J Ball, I M Franklin.   

Abstract

Bone marrow was cultured in vitro for colonies of granulocytes and macrophages five months after a patient had recovered from amodiaquine induced agranulocytosis. The addition of amodiaquine, chloroquine, and sulfadoxine to the culture was followed by a dose dependent inhibition of colony growth in the patient's marrow but not in normal control bone marrow. Colony growth was, however, unaffected by proguanil, pyrimethamine, and quinine. These findings show that in vitro marrow culture may have important predictive value in some cases of drug induced agranulocytosis.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3082409      PMCID: PMC1339776          DOI: 10.1136/bmj.292.6522.717

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  1 in total

1.  Amodiaquine-induced agranulocytosis: toxic effect of amodiaquine in bone marrow cultures in vitro.

Authors:  D E Lind; J A Levi; P C Vincent
Journal:  Br Med J       Date:  1973-02-24
  1 in total
  15 in total

Review 1.  Ascertainment of risk of serious adverse reactions associated with chemoprophylactic antimalarial drugs.

Authors:  P A Phillips-Howard; A B Bjorkman
Journal:  Bull World Health Organ       Date:  1990       Impact factor: 9.408

2.  Effect of monodesethyl amodiaquine on human polymorphonuclear neutrophil functions in vitro.

Authors:  M T Labro; J el Benna
Journal:  Antimicrob Agents Chemother       Date:  1991-05       Impact factor: 5.191

Review 3.  Antimalarial agents: specific chemoprophylaxis regimens.

Authors:  B L Herwaldt; D J Krogstad; P H Schlesinger
Journal:  Antimicrob Agents Chemother       Date:  1988-07       Impact factor: 5.191

4.  Development of recommendations for the protection of short-stay travellers to malaria endemic areas: Memorandum from two WHO Meetings.

Authors: 
Journal:  Bull World Health Organ       Date:  1988       Impact factor: 9.408

5.  Disposition of monodesethylamodiaquine after a single oral dose of amodiaquine and three regimens for prophylaxis against Plasmodium falciparum malaria.

Authors:  E Pussard; F Verdier; F Faurisson; J M Scherrmann; J Le Bras; M C Blayo
Journal:  Eur J Clin Pharmacol       Date:  1987       Impact factor: 2.953

Review 6.  Immunological principles of adverse drug reactions: the initiation and propagation of immune responses elicited by drug treatment.

Authors:  D J Naisbitt; S F Gordon; M Pirmohamed; B K Park
Journal:  Drug Saf       Date:  2000-12       Impact factor: 5.606

Review 7.  Treatment of malaria--1990.

Authors:  D M Panisko; J S Keystone
Journal:  Drugs       Date:  1990-02       Impact factor: 9.546

Review 8.  Prevention of malaria.

Authors:  J S Keystone
Journal:  Drugs       Date:  1990-03       Impact factor: 9.546

9.  Effects of amodiaquine, chloroquine, and mefloquine on human polymorphonuclear neutrophil function in vitro.

Authors:  M T Labro; C Babin-Chevaye
Journal:  Antimicrob Agents Chemother       Date:  1988-08       Impact factor: 5.191

10.  The toxicity of amodiaquine and its principal metabolites towards mononuclear leucocytes and granulocyte/monocyte colony forming units.

Authors:  P A Winstanley; J W Coleman; J L Maggs; A M Breckenridge; B K Park
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.